Shenzhen Jymed Technology Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is SEMAGLUTIDE, with a corresponding US DMF Number 36009.
Remarkably, this DMF maintains an Active status since its submission on May 04, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 20, 2023, and payment made on August 24, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II